To access this element change to forms mode OFF
Grant Award View - GA30016
The role of acetyl-CoA carboxylase enzymes in fatty liver disease and...
GA ID:
GA30016
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$564,999.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
The role of acetyl-CoA carboxylase enzymes in fatty liver disease and cancer
Purpose:
Non-alcoholic fatty liver disease (NAFLD) affects more than 5 million Australians and is an unmet medical need with no approved therapies. It is of vital importance to target NAFLD early before it progresses to cirrhosis, liver cancer, or liver failure. This project aims to reverse NAFLD progression by targeting enzymes involved in liver fat synthesis. The outcomes of this research will guide future drug development.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1163903
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA